Literature DB >> 22763821

Visual analogue scales: scale recalibration by patients with dementia and their proxies.

Alexander M M Arons1, Paul F M Krabbe, Gert Jan van der Wilt, Marcel G M Olde Rikkert, Eddy M M Adang.   

Abstract

BACKGROUND: Visual analogue scales (VAS) are often used to measure health-related quality of life (HRQoL). However, when such scales contain ambiguous anchors like "best imaginable health state," they produce answers that are difficult to interpret, as such anchors are interpreted differently by respondents of different age. This phenomenon that people's interpretation of subjective response scales changes in response to changing circumstances is known as scale recalibration. The current study attempts to investigate whether scale recalibration in a patient sample with cognitive limitations and proxies differs from the general population.
METHODS: The participants in the current study were 151 pairs of community-dwelling patients with dementia and their proxies. They were administered three VASs with different upper anchors; (A) "best imaginable health state," (B) "best imaginable health state for someone your age," and (C) "best imaginable health state for a 25-year-old." From literature, we inferred a conceptual model for the general population that predicts the ordinal relationship of the VASs to be B ≥ A ≥ C. This rank order is tested by repeated measure ANOVA's in the aforementioned populations.
RESULTS: VAS scores of patients with dementia were in line with the conceptual model. Proxy VAS scores for assessing patient HRQoL were not in line with the model: A > B > C. In addition, proxy VAS scores for assessing their own health were not in line with the model: A > B > C.
CONCLUSION: Patients with dementia use the VAS in a similar way to the general population. Proxies assessing either patients or themselves differ from the general population.

Entities:  

Mesh:

Year:  2012        PMID: 22763821      PMCID: PMC3664750          DOI: 10.1007/s11136-012-0226-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

1.  Clinical understanding and clinical implications of response shift.

Authors:  I B Wilson
Journal:  Soc Sci Med       Date:  1999-06       Impact factor: 4.634

2.  Integrating response shift into health-related quality of life research: a theoretical model.

Authors:  M A Sprangers; C E Schwartz
Journal:  Soc Sci Med       Date:  1999-06       Impact factor: 4.634

3.  Visual analog scales, standard gambles, and relative risk aversion.

Authors:  A Robinson; G Loomes; M Jones-Lee
Journal:  Med Decis Making       Date:  2001 Jan-Feb       Impact factor: 2.583

4.  Visual analog scales: do they have a role in the measurement of preferences for health states?

Authors:  G W Torrance; D Feeny; W Furlong
Journal:  Med Decis Making       Date:  2001 Jul-Aug       Impact factor: 2.583

Review 5.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  EQ-5D in patients with dementia: an investigation of inter-rater agreement.

Authors:  W Coucill; S Bryan; P Bentham; A Buckley; A Laight
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

8.  What is perfect health to an 85-year-old?: evidence for scale recalibration in subjective health ratings.

Authors:  Peter A Ubel; Aleksandra Jankovic; Dylan Smith; Kenneth M Langa; Angela Fagerlin
Journal:  Med Care       Date:  2005-10       Impact factor: 2.983

9.  Proxy reporting of quality of life using the EQ-5D.

Authors:  Hani Tamim; Jane McCusker; Nandini Dendukuri
Journal:  Med Care       Date:  2002-12       Impact factor: 2.983

10.  Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL.

Authors:  Linus Jönsson; Niels Andreasen; Lena Kilander; Hilkka Soininen; Gunhild Waldemar; Harald Nygaard; Bengt Winblad; Maria Eriksdotter Jönhagen; Merja Hallikainen; Anders Wimo
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

View more
  2 in total

1.  The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Authors:  Joaquin A Vizcarra; Álvaro Sánchez-Ferro; Walter Maetzler; Luca Marsili; Lucia Zavala; Anthony E Lang; Pablo Martinez-Martin; Tiago A Mestre; Ralf Reilmann; Jeffrey M Hausdorff; E Ray Dorsey; Serene S Paul; Judith W Dexheimer; Benjamin D Wissel; Rebecca L M Fuller; Paolo Bonato; Ai Huey Tan; Bastiaan R Bloem; Catherine Kopil; Margaret Daeschler; Lauren Bataille; Galit Kleiner; Jesse M Cedarbaum; Jochen Klucken; Aristide Merola; Christopher G Goetz; Glenn T Stebbins; Alberto J Espay
Journal:  Mov Disord       Date:  2019-03-22       Impact factor: 10.338

2.  Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.

Authors:  Amir I A Ahmed; Geke A H van den Elsen; Angela Colbers; Cornelis Kramers; David M Burger; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Psychopharmacology (Berl)       Date:  2015-03-11       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.